Company intelligence / Profile preview

Hongzhi New Materials

Quzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Hongzhi New Materials specializes in the development and manufacturing of medical-grade high-performance polymers, including PEEK, PPSU, and PES. Its products are widely commercialized as components for surgical instruments, orthopedic implants (such as spinal cages), and hemodialysis filters, meeting stringent biocompatibility and sterilization standards.

Therapeutic areas: CardiovascularNephrologyRheumatologyOther
Modalities: Device
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Hongzhi New Materials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hongzhi New Materials.

Explore the full profile